• 한국토양환경학회지
• /
• 제4권2호
• /
• pp.113-125
• /
• 1999

충남 서부 백동 사문암 지역에서 식물체내 중금속 오염정도를 알기 위해 사문암 지역과 각섬석 편암 및 편마암을 포함하는 인접 변성암으로 구성된 비 사문암 지역으로 나누어 식물체를 채취하였고 이들과 관계를 알기 위해 식물체가 서식하는 근접 지점에서 상부토양 및 모암시료도 채취 분석하였다. 이 결과 식물체에서 사문암 지역은 Ni. Cr, Co함량이, 비 사문암 지역은 Fe, Zn함량에서 각각 높았고 두 비사문암 지역 중 대부분 원소가 각섬석 편암 지역에서 높았다. 식물체내 평균 Ni, Co, Cr함량은 사문암, 각섬석 편암 및 편마암 순으로 감소하였고 쑥과 참억새의 절대원소함량은 사문암 지역에서 Fe, Ni 또는 Cr, Zn, Co, As, Sc순서로, 편마암 지역에서는 Fe, Zn, Cr, Ni순서로 감소했고 식물체 부분별 차이에서 대부분 원소에서 지하부가 높았다. 사문암과 편마암 지역 식물체 원소 함량 상대비에서 쑥에 비해 참억새가 대부분의 원소에서 낮은 값을 보였는데 이는 쑥보다 참억새가 척박한 사문암 토양내에서의 낮은 흡수량을, 그리고 비옥한 편마암 토양에서 높은 흡수량을 보이고 있음을 암시한다. 암석과 토양의 절대 원소 함량 비교에서 사문암 지역이 높은 Ni, Co및 Cr함량을 보였고, 이들 원소의 함량은 사문암, 각섬석 편암 및 편마암의 순으로 감소됐는데 이는 상부토양이 모암조성을 반영하기 때문일것으로 추정된다. 암석 및 상부토양의 절대 원소함량에서 사문암지역은 Fe, Cr또는 Ni, Co, Zn, As, Sc, 편마암지역은 Fe, Zn, Cr, Ni, Co또는 Sc순서로 각각 감소했으며 암석과 토양의 상대비는 사문암 지역이 Cr, As, Fe, Sc, Co, Ni, Zn, 편마암 지역은 Sc, Fe, Ni, Zn Cr, Co순서로 각각 감소했다. 상부토양과 식물체의 원소 함량 비교에서 토양이 대부분 원소에서 골았고, 각 원소의 증감에 따라 식물체와 토양은 유사한 경향을 보였다. 토양과 식물체의 각 원소 함량차이에서 사문암, 각섬석 편암, 편마암 순으로 감소했으며 편마암지역 토양이 식물체의 함량에 가장 근접했다. 토양과 식물체의 각 원소함량 관계에서 동종의 개체일지라도 상부토양차이에 따라서 식물체내 원소 흡수량은 상당한 차이를 보였다. 척박한 사문암 지역의 식물이 변성암 지역의 식물과 비교하여 높은 Ni, Co, Cr 함량을 보이면서도 생존하는 것은 이들 식물이 척박한 사문암 지역에서도 생존할 수 있는 내성종임을 암시한다. 상부지각 암석 평균치와 비교에서 사문암 지역의 쑥과 참억새는 상부지각 암석 평균치보다 Ni, Cr 함량에서 높았는데 이는 사문암 지역 식물체내에는 이들 원소들이 과량 축척되었음을 의미한다. 위 연구 결과와 기존 사문암을 모재로 발달된 중금속에 오염된 토양에 대한 연구들을 재고해 보았을 때 식물체를 이용한 토양내 중금속 제거를 위해서는 사문암 지역내 식물체의 생태학적인 연구와 중금속 축척정도등과 같은 추가적인 연구가 필요함을 강력히 암시한다.

• Clinical and Experimental Reproductive Medicine
• /
• 제12권1호
• /
• pp.47-70
• /
• 1985

This study was presented of the 1,872 cases of infertile couples who visited and examined at the sterility clinic of Department of Obstetrics & Gynecology, Seoul National University Hospital from Sept., 1980 to Dec., 1983. Age, duration of infertility, past medical history, and other general factors were analyzed, and the factors responsible for infertility were classified and discussed. Mode of treatment, outcome of pregnancy, pregnancy rate responsible for each factor were also presented. The results were as follows: 1) The infertility was primary in 1,128, or 60.3% and secondary in 744, or 39.7%. 2) The age between 26 and 30 years of age comprised about one half of the total patients. 3) The duration of infertility between 1 and 4 years comprised about three quarters of the total patients, and the mean duration was 3.8 years. 4) The most common medical history in primary infertility was tuberculous disease, and that in secondary infertility was history of previous laparotomy. 5) About two thirds of antecedent pregnancies were abortion. 6) The major etiologic factor of infertility were male factor in 12.3%, tubal factor in 38.8%, ovulatory failure in 25.4%, uterine factor in 8.8%, cervical factor in 5.2%, peritoneal factor in 9.5%, and no demonstrable cause in 11.3%. 7) The types of male factor were azoospermia in 61.6%, oligospermia in 25.8%, low motility in 11.6%, and other abnormality in 1.0%. 8) The types of ovulatory failure were ovarian failure in 7.4%, hypothalamo-pituitary failure in 8.1 %, hypothalamo-pituitary dysfunction (including Polycystic ovarian syndrome) in 30.2%, and hyperprolactinemia in 22.4%. 9) The types of uterine factor were endometrial tuberculosis in 27.5%, uterine synechia in 33.8%, uterine anomaly in 19.7%, myoma and polyp in 9.1 %, and luteal phase defect in 9.9%. 10) The types of peritoneal factor were pelvic adhesion in 80.9% and endometriosis in 19.6%. 11) Surgeries were done in 408 patients, and they were salpingolysis, lysis of extraadnexal adhesion, salpingostomy, fimbrioplasty, ovarian wedge resection for polycystic ovarian disease, tubo-tubal anastomosis, and tubo-uterine implantation in orders. 12) 243 pregnancies were achieved during the infertility work-up, of which livebirth was 46.5%, ectopic pregnancy was 7.4%, spontaneous abortion was 7.8%, and on-going pregnancy or lost to follow-up was 36.2%. 13) Pregnancy rates in various factors were male factor in 18.7%, ovulatory factor in 31.7%, tubal factor in 24.2%, uterine factor in 34.6%, cervical factor in 19.0%, peritoneal factor in 29.0%, combined factors in 10.5%, and unexplained infertility in 37.1%. Pregnancy rate in whole patients was 25.2%.

• 분석과학
• /
• 제26권6호
• /
• pp.401-406
• /
• 2013

유정란의 부화과정 동안 소모되는 산소와 배출되는 이산화탄소의 양을 기체질량분석기를 사용하여 측정하였다. 20 일에 걸친 유정란과 무정란의 인공부화 과정 동안 기체 시료를 채취하기 위해 밀폐된 구조의 시료 챔버를 제작하였다. 2~4 일 간격으로 시료 챔버 안에 유정란을 1 시간 동안 방치한 후, 실린지를 이용해 밀폐된 시료 챔버로부터 2 mL의 기체 시료를 채취한 후 기체질량분석기를 사용하여 분석하였다. 인공부화를 시작한 후 약 10 일 후부터 닭 배아의 산소 소모량과 이산화탄소 배출량이 급격히 증가하였다. 20 일 후에는 시간당 23 mL의 산소를 소모하고 16 mL의 이산화탄소를 배출하였다. 전체 부화 기간 동안 산소의 농도는 4.3 mol% 감소하였고 이산화탄소의 농도는 3.1 mole% 증가하여 소모된 산소의 몰수와 배출된 이산화탄소의 몰수가 같지 않았다. 한편, 동일한 기간 동안 질소의 농도는 약 1.3 mol% 증가하였으며 그 증가된 농도는 소모된 산소와 배출된 이산화탄소의 농도변화량의 차이와 비슷한 값을 보였다. 따라서 질소의 몰분율 증가는 소모된 산소와 배출된 이산화탄소 간의 몰분율 차이에 의한 것임을 알 수 있었다. 본 연구에서는 기체의 조성 변화량을 정확히 측정하여 유정란의 부화과정 중 호흡현상을 설명할 수 있었다.

• Clinical and Experimental Reproductive Medicine
• /
• 제44권4호
• /
• pp.207-213
• /
• 2017

Objective: This study investigated the prevalence of infections with human papillomavirus, Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, and Mycoplasma genitalium in the semen of Korean infertile couples and their associations with sperm quality. Methods: Semen specimens were collected from 400 men who underwent a fertility evaluation. Infection with above five pathogens was assessed in each specimen. Sperm quality was compared in the pathogen-infected group and the non-infected group. Results: The infection rates of human papillomavirus, C. trachomatis, U. urealyticum, M. hominis, and M. genitalium in the study subjects were 1.57%, 0.79%, 16.80%, 4.46%, and 1.31%, respectively. The rate of morphological normality in the U. urealyticum-infected group was significantly lower than in those not infected with U. urealyticum. In a subgroup analysis of normozoospermic samples, the semen volume and the total sperm count in the pathogen-infected group were significantly lower than in the non-infected group. Conclusion: Our results suggest that infection with U. urealyticum alone and any of the five sexually transmitted infections are likely to affect sperm morphology and semen volume, respectively.

• Clinical and Experimental Reproductive Medicine
• /
• 제23권1호
• /
• pp.11-24
• /
• 1996

The number of multifetal pregnancies has increased dramatically as a result of the widespread clinical use of ovulation induction and assisted reproductive technology(ART) in infertile patients. In multifetal pregnancies, the adverse outcome is directly proportional to the number of fetuses within the uterus, primarily because of an increased predisposition to premature delivery. It is extremely difficult to counsel patients about the expected outcome of pregnancies involving three or more fetuses. To increase the chances of delivering infants mature enough to survive without being irreversibly damaged by the sequelae of marked prematurity, selective fetal reduction(SFR) to the smaller number of fetuses should be considered in multifetal pregnancies. From January, 1991 to December, 1992, transabdominal SFR in multifetal pregnancies was performed in 22 patients including 13 triplet, 7 quadruplet, 1 quintuplet and 1 heptuplet pregnancies. Transabdominal SFR using intracardiac KCI injection and aspiration of amniotic fluid was carried out in 8-13 weeks of gestation. After procedure, 20 patients were remained as twin pregnancies, and 2 patients as triplet pregnancies. There have been 11 sets of twin delivery including 2 stillbirths, 2 sets of triplet delivery including 1 stillbirth, and 1 singleton delivery. Six cases were delivered after 37 weeks of gestation, 4 cases in 33 - 37 weeks, and 1 case in 30 weeks. Unfortunately, 3 stillbirths occurred in 20-24 weeks of gestation, and 4 cases were aborted. As 7 losses of pregnanancy including 1 case of septic abortion occurred, the delayed fetal loss rate was 38.9%(7/18) in transabdominal SFR. All babies born after 30 weeks of gestation were healthy, and no fetal anomaly directly related to the procedure was encountered. From July, 1993 to February, 1995, transvaginal SFR was performed in 20 patients including 15 triplet, 4 quadruplet and 1 quintuplet pregnancies. Transvaginal SFR using the same method as transabdominal SFR was carried out in 8-11 weeks of gestation. After procedure, 19 patients were remained as twin pregnancies, and 1 patient as singleton pregnancy. There have been 13 sets of twin delivery including 2 stillbirths, and 1 singleton delivery. Six cases were delivered after 37 weeks of gestation, 5 cases in 36-37 weeks, and 1 case in 30 weeks. Unfortunately, 2 still-births occurred in 20 weeks and 21 weeks of gestation, respectively, and 2 cases were aborted. As 4 losses of pregnancy including 1 case of septic abortion occurred, the delayed fetal loss rate was 25.0%(4/16) in transvaginal SFR. No fetal anomaly directly related to the procedure was encountered. It is suggested that transvaginal SFR could be performed more easily and earlier with the lower fetal loss rate as compared with transabdominal SFR. In conclusion, SFR is a rather safe and ethically justified procedure that may improve the outcome of multifetal pregnancies.

• Clinical and Experimental Reproductive Medicine
• /
• 제28권3호
• /
• pp.225-233
• /
• 2001

Objective : To evaluate the efficacy of low-dose aspirin on IVF outcome and endometrium in patients undergoing IVF-ET. Materials and Methods : From February, 2001 to Jun, 2001, 60 infertile patients were randomly divided into study group (28 cycles) and control group (32 cycles). The study group received a daily oral dose of 25 mg of aspirin for at least 2 weeks from first visiting day. Controlled ovarian hyperstimulation was initiated in all patients with the GnRH agonist starting in the midluteal phase of the previous cycle. Results: There were no significant differences in age of the patients, basal serum E2, LH, FSH level and endometrial thickness among two groups. There were no statistically significant differences between the study group and the control group respectively in dosage ($26.5{\pm}4.8$ vs $26.2{\pm}5.3$ amples) and duration ($10.4{\pm}4.2$ vs $9.8{\pm}5.3$ days) of gonadotropin administration, serum E2 level on the hCG administration day ($1823{\pm}342$ vs $1854{\pm}543$), LH ($14.5{\pm}2.7$ vs $14.8{\pm}3.1$), FSH ($16.7{\pm}3.4$ vs $18.3{\pm}4.7$), the number of follicles > 15 mm ($13.2{\pm}6.3$ vs $12.8{\pm}5.9$), the number of oocytes retrieved ($9.2{\pm}2.4$ vs $8.4{\pm}1.7$), the number of embryos transferred ($4.7{\pm}2.0$ vs $4.7{\pm}2.0$), fertilization rate (68.4% vs 64.5%), implantation rate (21.3% vs 17.6%), and clinical pregnancy rate (28.4% vs 26.2%). The endometrial thickness and the percentage of endometrial trilaminar pattern on hCG day were significantly higher in study group than control group ($12.9{\pm}3.7mm$ vs $10.4{\pm}2.8mm$, 78.3% vs 64.5%). Conclusion: Many reports suggest that low-dose aspirin improve ovarian response, implantation rate, fertilization rate, implantation rate, and pregnancy rate by increasing the blood flow, but we couldn't prove the significant effect of low-dose aspirin on the IVF outcome except on endometrium. This may be affected by dose of aspirin, duration, and number of patients studied. This trial is small, so our results highlight the need for a large randomized controlled trial to identify the effect of low-dose as pirin on IVF-ET outcome.

• Clinical and Experimental Reproductive Medicine
• /
• 제28권3호
• /
• pp.215-223
• /
• 2001

Objective: The purpose of this study was to make a guideline of uterine artery embolization for the treatment of uterine leiomyomas accompanying with adenomyosis in Korea. Materials and Methods : We performed the retrospective study for 37 women who had uterine leiomyomas accompanying with adenomyosis. Bilateral uterine artery embolization was performed in 37 patients (age range 25-65) during 17 months with pain, hypermenorrhea, urinary frequency etc due to leiomyomas. Ultrasound imaging was performed before the procedure and at mean 6.9 months after the procedure. Results: All procedures were technically successful. Mean clinical follow-up was 12.8 months. Minor complication occurred in 82% patients after the procedure. After imaging follow-up (mean, 6.9 months postprocedure), median uterine volume decreased 34.4%, and dominant myoma volume decreased 86%. There was no statistical difference in uterine volume reduction and dominant myoma size reduction whether occluding agents was polyvinyl alcohol, polyvinyl alcohol plus gelfoam, and gelfoam, and whether ultrasound measured Resistance Index value before the procedure was low or high. Conclusion: Primary candidates for uterine artery embolization include those with symptomatic uterine leiomyomas who no longer des ire fertility but wish to avoid surgery or are poor surgical risks. To our study, uterine volume reduction and dominant myoma size reduction in patients who had adenomyosis were similar to previous other studies in patients who had not adenomyosis. Therefore adenomyosis should not be considered as a contraindication for uterine artery embolization. Because there is little data about subsequent reproductive potential after this procedure, it should not be routinely advocated for infertile women. Further investigation is warranted for occluding agents and Resistance Index.

• 한국자원식물학회지
• /
• 제20권1호
• /
• pp.73-78
• /
• 2007

교배효율의 증대를 위해서는 정상화분의 확보가 선행되어야하며 화분의 활성을 파악할 필요가 있다. 본 연구에서는 화분의 활성을 확인하기 위해 여러 가지 염색액을 사용하여 광학현미경하에서 관찰하였다. Aceto-carmine과 Alexander's 염색액을 사용한 실험에서 비슷한 정상화분율을 얻을 수 있었고 FCR염색으로 관찰한 결과 살아있는 화분만 정확히 선별해 주기에 가장 낮은 정상화분율을 얻을 수 있었다. TB는 화분의 상태에 따라 달랐으나 Aceto-carmine과 Alexander's 염색액을 사용한 실험에서의 결과와 비슷한 양상을 보였다. 화분 관찰의 경험이 별로 없는 실험자도 쉽게 접근할 수 있는 염색액은 Alexander's 이었다. 정확한 화분의 활성을 조사하는 데에는 FCR이 필수이다. 형광현미경 장치 없이 정상과 비정상화분의 구별이 용이한 Alexander's 염색액으로 관찰한 자료를 바탕으로 살아있는 정상화분율의 예견이 가능하나 정확한 임성을 확인하려면 추가로 FCR test를 해야 한다.

• 한국발생생물학회지:발생과생식
• /
• 제15권4호
• /
• pp.385-391
• /
• 2011

인간의 불임을 극복하고 치료하기 위한 체외수정 및 배아이식술(in vitro fertilization and embryo transfer: IVF-ET)의 성공적인 임신과 출산은 1978년 영국에서 세계 최초로 성공 사례를 보고하였으며, 국내에서는 1986년에 처음으로 보고되었다. 최근에 발표된 보건복지부 통계자료에 의하면 2010년에는 130여 개의 배아생성의료기관에서 연간 42,000 건 이상의 IVF-ET가 시행되었다고 한다. 이러한 시술에 사용되는 재료 및 소모품으로는 난자 채취에 사용되는 난자채취용 주사침(ovum pick-up needle), 채취된 정자를 수세하고 분리하는데 사용되는 원심분리관(centrifuge tube), 난포액에서 난자를 확인하고 이를 분리할 때 사용하는 페트리 접시(Petri dish), 난자와 배아를 배양하는 배양접시(culture dish), 세포질내 정자주입술에 사용되는 미세 피펫(ICSI pipette), 배아의 체외배양에 사용되는 배양액(culture medium)과 미네랄 오일(mineral oil), 정자를 자궁에 넣어주는 인공수정에 사용되는 이식관(intrauterine insemination catheter), 배아의 이식에 사용되는 이식관(embryo transfer catheter), 잉여의 배아를 동결하기 위한 동결액(cryopreservation solution) 그리고 체외배양공간을 제공하는 배양기(incubator) 등이 있다. 그러나 대부분의 시술 재료와 소모품들이 수입에 의존하고 있어, 수입의존도를 낮추고 국산화를 도모하기 위해 시술기관의 임상의와 연구원들을 대상으로 체외수정 및 배아이식술 관련 시술 재료와 소모품 국산화에 대한 설문 조사를 실시한 결과를 분석하였다. 관련 분야의 임상의와 연구원들도 국산화에 대한 공감대를 가지고 있음을 확인할 수 있었다. 실제적으로 국산화가 성공되기 위해서는 품질보증과 품질관리와 같은 체계적인 시스템의 도입이 필요하며, 이를 통해 관련 산업의 발전과 국제적인 경쟁력을 강화할 수 있을 것으로 기대된다.

• 한국수정란이식학회지
• /
• 제26권2호
• /
• pp.97-104
• /
• 2011

This study was carried out to confirm the effects of luteotrophin, human chorionic gonadotrophin (hCG), and an anti-luteolytic agent, flunixin meglumin (FM), on pregnancy rates in Hanwoo with in vitro produced (IVP) embryo transfers (ET), and to research the effects on the estrus cycle. Treatments included hCG and FM administration 3~10 minutes prior to ET. Also, pregnancy rates were compared with lidocane treatment and FM treatment prior to ET. The results are shown below. 30-day pregnancy rate was 76.7% in the hCG-treated group and 75.7% in the FM-treated group. Both rates were higher than the 70% rate for the control group. 42-day pregnancy rate was 76.7% in the FM-treated group. This was higher than 66.7% recorded for both the hCG-treated and control groups. The pregnancy rate of the hCG-treated group was high at Day 30 (76.7%) but low at Day 40 (66.7%), and there were no differences from the FM-treated and control groups. The recurrent estrus rate of infertile individuals at 2 weeks after ET was 36.4% in the hCG-treated group, under 71.4% in the FM-treated group and 80.0% in the control group. The non-pregnancy rate of individuals without recurrent estrus was 18.2% in the hCG-treated group, which was higher than the 0% rate in both the FM-treated and control groups. The pregnancy rates were higher in the FM-treated group than the Lidocane-treated group with 72.3% versus 67.5% in the heifers and 48.9% versus 43.6% in the cows. From the above results, the FM treatment proved more effective than the hCG treatment and no treatment whatsoever in increasing pregnancy rates after ET. In addition, hCG treatment was shown to be undesirable due to the deviations it caused in the reproductive physiology of the hCG-treated recipients. Therefore, in our study, the FM treatment resulted in a higher pregnancy rate than either lidocaine treatment or no-treatment in the trials of ET.